COMMUNIQUÉS West-GlobeNewswire

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated
08/02/2025
ZUG, Switzerland, Feb. 08, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares. Attachments Notification of [...]
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
07/02/2025
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO, Calif., Feb. 07, [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
BRISBANE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeutics to fight cancer [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs [...]
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
07/02/2025
IRVINE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
WOBURN, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of [...]
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/02/2025
NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period
07/02/2025
This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and [...]
Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members
07/02/2025
BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non- [...]
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
07/02/2025
WARREN, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech company, met the Center for the Biomedical [...]
WAKE RADIOLOGY PROMOTES HEART HEALTH WITH ADVANCED IMAGING SERVICES AND SCREENINGS DURING FEBRUARY
07/02/2025
Raleigh, N.C., Feb. 07, 2025 (GLOBE NEWSWIRE) -- This National Wear Red Day, Wake Radiology is raising awareness for heart health by offering advanced cardiac imaging services and encouraging participation in Heart [...]
OHC - Ford government’s primary care announcement plays politics with people’s need for a family doctor: It’s a primary care “plan” to implement a plan delayed until the cusp of an election
07/02/2025
TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- No matter how anyone tries to spin the numbers, the actual data from sources not tainted by politics, show that more than a million Ontarians have lost their family doctor [...]
Le CMUH recommande RYBREVANT®▼ (amivantamab) par voie sous-cutanée dans le cadre du traitement des patients atteints d’un cancer du poumon non à petites cellules avancé avec mutations de l’EGFR
07/02/2025
Les données issues de l’étude de Phase 3 PALOMA-3 ont révélé une non-infériorité par rapport à l’administration intraveineuse pour les deux co-critères d’évaluation pharmacocinétiques principaux, ainsi qu’une division [...]
Carla da Luz Boren Recognized Among Top 50 Women Leaders in Healthcare Technology
07/02/2025
WESTWOOD, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical announced that Carla da Luz Boren, J.D., the Company’s chief human resources officer, has been named among the Top 50 Women Leaders in Healthcare [...]
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
07/02/2025
Patient treated in procedure, conducted at Mass General Transplant Center and in collaboration with partner eGenesis, was recently released from hospital Investigational therapy tegoprubart targets CD40 ligand (CD40L) [...]
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
07/02/2025
Current Board’s Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 Months New Leadership is Urgently Needed to Restore Accountability in the Boardroom Restore Value [...]

Pages